PT - JOURNAL ARTICLE AU - Roesner, Lennart M. AU - Farag, Ahmed K. AU - Pospich, Rebecca AU - Traidl, Stephan AU - Werfel, Thomas TI - T cell receptor sequencing specifies psoriasis as a systemic and atopic dermatitis as a skin-focused, allergen-driven disease AID - 10.1101/2021.07.14.21260435 DP - 2022 Jan 01 TA - medRxiv PG - 2021.07.14.21260435 4099 - http://medrxiv.org/content/early/2022/02/02/2021.07.14.21260435.short 4100 - http://medrxiv.org/content/early/2022/02/02/2021.07.14.21260435.full AB - Background Atopic dermatitis (AD) and psoriasis represent two of the most common inflammatory skin diseases in developed countries. A hallmark of both diseases is T cell infiltration into the skin. However, it is still not clarified to what extent these infiltrating T cells are antigen-specific skin-homing T cells or unspecific heterogeneous bystander cells.Methods To elucidate this, T cells from lesional skin and from blood of 9 AD and 10 psoriasis patients were compared by receptor (TCR) sequencing. Therefore, peripheral blood mononuclear cells (PBMC) were cell-sorted according to expression of the cutaneous leukocyte antigen (CLA) into skin-homing (CLA+) and non-skin-homing (CLA-) subfractions. Aeroallergen-specific T cell lines were grown from AD patients’ PBMC in parallel.Results Intra-individual comparison of TCRB CDR3 regions revealed that clonally expanded T cells in skin lesions of both AD and psoriasis patients corresponded to skin-homing circulating T cells. However, in psoriasis patients, these T cell clones were also detectable to a larger extent among CLA- circulating T cells. Up to 28% of infiltrating cells in AD skin were identified as allergen-specific by overlapping TCR sequences.Conclusions Our data shows that in line with the systemic nature of psoriasis, T cell clones that infiltrate psoriatic skin lesions do not exclusively possess skin-homing ability and are therefore most probably specific to antigens that are not exclusively expressed or located in the skin. T cells driving AD skin inflammation appear to home nearly exclusively to the skin and are, to a certain extent, specific to aeroallergens.Competing Interest StatementLMR declares grants to his institution and personal fees from Novartis. AKF is an employee of Boehringer Ingelheim GmbH. ST received consultancy fees from LEO Pharma, Lilly, and La Roche Posay. RP declares that she has no competing interests. TW has received institutional research grants from LEO Pharma and Novartis, has performed consultancies for Abbvie, Janssen, Galderma, LEO, Sanofi-Genzyme, and Novartis, he has also lectured at educational events sponsored by Abbvie, Janssen, Celgene, Galderma, LEO Pharma, Sanofi and Novartis and is involved in performing clinical trials with various pharmaceutical industries that manufacture drugs used for the treatment of and atopic dermatitis.Funding StatementInstitutional funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Internal Review Board of Hannover Medical School.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the main text or the supplementary materials.